AB
NVO

AT Bancorp’s Novo Nordisk NVO Stock Holding History

AT Bancorp’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-16,440
Closed -$353K – 275
2017
Q2 		$353K Sell
16,440
-35,364
-68% -$714K 0.04% 195
2017
Q1 		$888K Hold
51,804
– – 0.11% 162
2016
Q4 		$929K Sell
51,804
-26,788
-34% -$486K 0.12% 146
2016
Q3 		$1.63M Sell
78,592
-33,930
-30% -$841K 0.22% 93
2016
Q2 		$3.03M Sell
112,522
-8,662
-7% -$238K 0.45% 68
2016
Q1 		$3.28M Buy
+121,184
New +$3.25M 0.49% 61

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

AT Bancorp's NVO Position: Q3 2017 in Review

AT Bancorp sold out of Novo Nordisk (NVO) in Q3 2017, closing a stake of 16,440 shares — an estimated $353K sold.

AT Bancorp first reported a position in NVO in Q1 2016 and held it in 6 quarters. The position peaked at $3.28M in Q1 2016. 491 funds tracked by Wall St. Rank hold NVO as of Q3 2017.

  • AT Bancorp reported no remaining Novo Nordisk position as of Q3 2017 after selling out during the quarter.
  • AT Bancorp sold 16,440 Novo Nordisk shares in Q3 2017, an estimated $353K.
  • AT Bancorp first reported a position in Novo Nordisk in Q1 2016 and held it in 6 quarters.
  • AT Bancorp's Novo Nordisk position peaked at $3.28M in Q1 2016.
  • 491 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2017.

Based on AT Bancorp's 13F filing for Q3 2017, filed 8 Nov 2017.